Virax Biolabs Group Limited (VRAX) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 1.61K | 1.38K | 4.95K | 79.92K | 76.5K | 2.8K | 5.76K | -92.86K | 0 | 109.82K | 24.97K |
| Revenue Growth % | -67.53% | -98.28% | -93.53% | 2753.23% | 1228.13% | 103.02% | - | -184.56% | - | 339.83% | - |
| Cost of Goods Sold | 217.02K | 47.97K | 11.43K | 39.85K | 65.98K | 4.28K | 5.64K | 99.94K | 0 | 133.25K | 13.53K |
| COGS % of Revenue | 13496.39% | 3481.2% | 230.71% | 49.86% | 86.25% | 152.95% | 97.95% | -107.62% | - | 121.34% | 54.19% |
| Gross Profit | -215.41K | -46.59K | -6.47K | 40.07K | 10.52K | -1.48K | 118 | -192.81K | 0 | -23.43K | 11.44K |
| Gross Margin % | -13396.39% | -3381.2% | -130.71% | 50.14% | 13.75% | -52.95% | 2.05% | 207.62% | - | -21.34% | 45.81% |
| Gross Profit Growth % | -3227.37% | -216.27% | -161.55% | 2802.09% | 8813.56% | 99.23% | - | -722.76% | - | -304.88% | - |
| Operating Expenses | 2.37M | 3.24M | 2.87M | 3.83M | 2.72M | 4.29M | 1.44M | 1.17M | 566.74K | 249.65K | 176.79K |
| OpEx % of Revenue | 147391.85% | 234935.63% | 57993.48% | 4792.76% | 3551.3% | 153184.65% | 25012.05% | -1256.6% | - | 227.32% | 708.03% |
| Selling, General & Admin | 990.32K | 2.18M | 2.15M | 2.29M | 2.31M | 3.99M | 1.34M | 841.29K | 458.64K | 187.92K | 154.42K |
| SG&A % of Revenue | 61586.82% | 158492.24% | 43327.38% | 2862.02% | 3016.27% | 142456.8% | 23334.58% | -905.93% | - | 171.12% | 618.45% |
| Research & Development | 1.38M | 1.05M | 726.41K | 1.15M | 409.3K | 300.49K | 96.62K | 325.65K | 108.1K | 61.72K | 21.75K |
| R&D % of Revenue | 85805.04% | 76443.4% | 14666.1% | 1442.3% | 535.03% | 10727.85% | 1677.47% | -350.67% | - | 56.2% | 87.11% |
| Other Operating Expenses | 0 | 0 | 0 | 390.36K | 0 | 0 | 0 | 519.23K | 0 | 0 | 618 |
| Operating Income | -2.59M | -3.28M | -2.88M | -3.79M | -2.71M | -4.29M | -1.44M | -1.17M | -566.74K | -273.08K | -162.81K |
| Operating Margin % | -160788.25% | -238316.84% | -58124.19% | -4742.61% | -3537.54% | -153237.77% | -25010.07% | 1256.6% | - | -248.66% | -652.05% |
| Operating Income Growth % | 10.19% | 13.36% | -6.38% | 11.69% | -87.86% | -267.82% | -154.19% | -327.33% | - | -67.73% | - |
| EBITDA | -2.37M | -3.14M | -2.77M | -3.7M | -2.69M | -5 | -4 | -1 | 0 | -1 | -154.94K |
| EBITDA Margin % | -147311.82% | -227823.29% | -55861.18% | -4635.78% | -3514.38% | -0.18% | -0.07% | 0% | - | -0% | -620.52% |
| EBITDA Growth % | 14.39% | 15.26% | -2.91% | -74097300% | -67212425% | -400% | - | 0% | - | 100% | - |
| D&A (Non-Cash Add-back) | 216.7K | 144.6K | 112.09K | 85.38K | 17.72K | 4.29M | 1.44M | 1.17M | 566.74K | 273.08K | 7.87K |
| EBIT | -2.59M | -3.28M | -2.88M | -3.81M | -2.71M | -4M | -1.44M | -1.17M | -560.9K | -272.82K | -162.19K |
| Net Interest Income | -30.99K | -32.59K | -25.59K | -16.76K | 0 | 0 | 0 | 0 | 0 | 0 | -22.67K |
| Interest Income | 0 | 0 | 0 | 0 | 10.11K | 5.86K | 9.61K | 1.29K | 14.14K | 10.51K | 0 |
| Interest Expense | 30.99K | 32.59K | 25.59K | 16.76K | 10.11K | 5.86K | 9.61K | 1.29K | 14.14K | 10.51K | 22.67K |
| Other Income/Expense | -31.39K | -26.66K | -14.33K | -34.67K | -207.98K | 288.21K | -13.21K | -7.89K | -8.3K | -10.25K | -22.05K |
| Pretax Income | -2.62M | -3.31M | -2.89M | -3.82M | -2.91M | -4M | -1.45M | -1.17M | -575.04K | -283.33K | -184.87K |
| Pretax Margin % | -162740.49% | -240251.67% | -58413.59% | -4785.99% | -3809.42% | -142948.13% | -25239.34% | 1265.09% | - | -258% | -740.38% |
| Income Tax | -273.59K | 0 | -136.66K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -7.87K |
| Effective Tax Rate % | 10.46% | 0% | 4.72% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 4.26% |
| Net Income | -2.34M | -3.3M | -2.76M | -3.82M | -2.91M | -4.01M | -1.44M | -1.16M | -552.42K | -307.53K | -176.99K |
| Net Margin % | -145445.96% | -239827.29% | -55651.67% | -4784.7% | -3803.47% | -143301.79% | -25062.69% | 1245.26% | - | -280.03% | -708.85% |
| Net Income Growth % | 15.15% | 13.57% | 5.27% | 4.73% | -101.55% | -247.1% | -161.33% | -276.04% | - | -73.75% | - |
| Net Income (Continuing) | -2.34M | -3.31M | -2.76M | -3.82M | -2.91M | -4M | -1.45M | -1.17M | -575.04K | -283.33K | -176.99K |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | -238.47K | -233.97K | -228.12K | -227.98K | -226.95K | -222.4K | -236.76K | -222.13K | -203.74K | -181.13K | 0 |
| EPS (Diluted) | -0.49 | -0.76 | -0.89 | -1.71 | -1.64 | -2.58 | -1.24 | -1.02 | -0.49 | -0.27 | -0.02 |
| EPS Growth % | 44.94% | 55.56% | 45.73% | 33.72% | -32.26% | -152.94% | -153.06% | -277.78% | - | -1630.77% | - |
| EPS (Basic) | -0.49 | -0.76 | -0.89 | -1.71 | -1.64 | -2.58 | -1.24 | -1.02 | -0.49 | -0.27 | -0.02 |
| Diluted Shares Outstanding | 4.76M | 4.36M | 3.1M | 2.24M | 1.78M | 1.55M | 1.17M | 1.14M | 1.14M | 1.14M | 11.37M |
| Basic Shares Outstanding | 4.76M | 4.36M | 3.1M | 2.23M | 1.78M | 1.55M | 1.17M | 1.14M | 1.14M | 1.14M | 11.37M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - |